GAMMADELTA THERAPEUTICS
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.
GAMMADELTA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gammadeltatx.com
Total Employee:
51+
Status:
Closed
Contact:
+44 (0207) 6911122
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Person Schema Gravatar Profiles Amazon Route 53 DMARC AWS Global Accelerator
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Carbylan Therapeutics
Carbylan Therapeutics was founded in 2004
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
ieso
Transforming mental healthcare by unlocking the power of clinical data
Imutex
Imutex, a startup with a Phase IIa-ready universal flu vaccine.
Mavalon Therapeutics
Mavalon is developing drugs to stop the progression of Parkinson's disease.
My Personal Therapeutics/ VIVAN Therapeutics
My Personal Therapeutics (MPT) is a company pioneering personalized cancer therapeutics using a new assay technology.
Orbus Therapeutics
Orbus Therapeutics is dedicated to developing products that treat rare diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
StemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Stromal Therapeutics
Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.
Treos Bio
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-31 | Lymphact | Lymphact acquired by GammaDelta Therapeutics | N/A |
Investors List
Abingworth
Abingworth investment in Venture Round - GammaDelta Therapeutics
Takeda Ventures
Takeda Ventures investment in Venture Round - GammaDelta Therapeutics
Cancer Research Horizons
Cancer Research Horizons investment in Seed Round - GammaDelta Therapeutics
King's College London
King's College London investment in Seed Round - GammaDelta Therapeutics
The Francis Crick Institute
The Francis Crick Institute investment in Seed Round - GammaDelta Therapeutics
Abingworth
Abingworth investment in Seed Round - GammaDelta Therapeutics
Official Site Inspections
http://www.gammadeltatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.33 K
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 76.223.3.151
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
